Legislative record
HF 4852STATE · MinnesotaIn Committee
Formulary Committee members with a potential conflict of interest permitted to participate in committee communications and discussions, commissioner of human services required to develop a public comment process for recommendations, and committee required to seek expertise from the Minnesota Rare Disease Advisory Council.
Latest action: Introduction and first reading, referred to Health Finance and Policy
Voted 4/7/2026